insider trading

Trupanion CFO completed nine-month systematic stock divestment of 19,859 shares via pre-planned 10b5-1 trading arrangement, signaling financial diversification rather than company concerns.

C3.ai executive chairman sold $4.4M in shares via pre-planned trading arrangement amid 46% revenue decline and CEO transition.

Portnoy Law Firm files class action against $PMI for alleged fraud involving social media misinformation and insider share dumping. Stock crashed 70% in October.

Rosen Law Firm filed securities class action against Concorde International Group ($CIGL) alleging fraudulent promotion schemes and insider share dumping. Affected investors must act before critical deadlines.

Rep. Pfluger sells Warner Bros. Discovery stock despite 150% annual gain amid DOJ review of Paramount-Skydance merger.

Maze Therapeutics president Harold Bernstein sold all 30,000 shares for $1.51M via pre-arranged trading plan, weeks before Q4 earnings report.

Picard Medical faces securities fraud lawsuit alleging false statements, social media manipulation, and insider share dumping scheme during September-October 2025 period.

Rosen Law Firm urges PomDoctor investors to join securities class action by April 7, 2026 deadline alleging false statements, social media fraud, and insider share dumping.

Rosen Law Firm files securities class action against $CIGL, alleging fraudulent promotion, insider dumping, and false disclosures between April-July 2025.

GN Store Nord CEO Peter Karlströmer purchases 30,000 shares at DKK 93.03 average price, signaling management confidence in the hearing aid and professional audio company.

SentinelOne CEO sold $510K in shares for tax obligations as stock declined 21.56% annually, though analysts see attractive valuation amid strong 22% revenue growth.

Nokia board member Thomas Dannenfeldt sold 33,500 shares at €6.9944 each, raising investor questions about insider confidence in the Finnish telecom company.

Class action filed against Picard Medical ($PMI) for alleged securities fraud involving false promotions, insider share dumping, and omitted risk disclosures. Lead plaintiff deadline April 3, 2026.

Class action filed against PomDoctor ($POM) alleging stock fraud through false statements, social media misinformation, and coordinated insider share dumping.

Rosen Law Firm urges PomDoctor Ltd. investors with $100k+ losses to join securities fraud class action before April 7, 2026 deadline, alleging false statements and stock manipulation scheme.

$PMI stock crashed 70% after fraudulent social media scheme exposed. Shareholders urged to join securities fraud class action lawsuit by April 3, 2026.

Class action lawsuit filed against $PMI over alleged stock promotion fraud, insider dumping, and disclosure failures. Stock crashed from undisclosed price to $3.99, now trading near $2.00.

Rosen Law Firm urges PomDoctor Ltd. investors to join securities class action before April 7, 2026 deadline. Allegations include false statements, insider dumping, and artificial trading schemes.

Rosen Law Firm alerts investors in multiple securities litigation cases, including $PMI, urging them to secure counsel before critical claim deadlines.

Fastly CEO sells $1.2M in stock via pre-planned trading program. Stock surged 265.5% on AI boom but trades at multi-year valuation high.